MedPath

A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients

Phase 3
Completed
Conditions
HIV Infections
Registration Number
NCT00002410
Lead Sponsor
Dupont Merck
Brief Summary

The purpose of this study is to compare the safety and effectiveness of three anti-HIV drug combinations. The three combinations are: (1) efavirenz (DMP 266) plus indinavir; (2) DMP 266 plus zidovudine (ZDV) plus lamivudine (3TC); and (3) indinavir plus ZDV plus 3TC. This study also examines the resistance HIV may have to these drugs and if these drugs are effective over a long period of time.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (40)

Bach and Godofsky

πŸ‡ΊπŸ‡Έ

Bradenton, Florida, United States

Oasis Clinic / Martin Luther Jr Gen Hosp / King-Drew Med Ctr

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Remington-Davis Inc

πŸ‡ΊπŸ‡Έ

Columbus, Ohio, United States

Division of Infectious Disease / Dept of Internal Medicine

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

Philadelphia FIGHT

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Blick Med Associates

πŸ‡ΊπŸ‡Έ

Stamford, Connecticut, United States

Med College of Georgia

πŸ‡ΊπŸ‡Έ

Augusta, Georgia, United States

Community Research Initiative of South Florida

πŸ‡ΊπŸ‡Έ

Coral Gables, Florida, United States

Clinical Directors Network / HIV/AIDS Program Manager

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Boulevard Comprehensive Care Ctr

πŸ‡ΊπŸ‡Έ

Jacksonville, Florida, United States

Kraus Med Group

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Richard Stryker

πŸ‡ΊπŸ‡Έ

Beverly Hills, California, United States

Larry Marc Bush / c/o Sally Yantis

πŸ‡ΊπŸ‡Έ

Lake Worth, Florida, United States

Oyster Point Med Specialists

πŸ‡ΊπŸ‡Έ

Newport News, Virginia, United States

Paul Cimoch

πŸ‡ΊπŸ‡Έ

Irvine, California, United States

Univ of Kentucky Med Ctr

πŸ‡ΊπŸ‡Έ

Lexington, Kentucky, United States

Georgia Research Associates

πŸ‡ΊπŸ‡Έ

Atlanta, Georgia, United States

Treasure Coast Infectious Disease Consultants

πŸ‡ΊπŸ‡Έ

Vero Beach, Florida, United States

The Miriam Hosp

πŸ‡ΊπŸ‡Έ

Providence, Rhode Island, United States

Wake Forest Univ School of Medicine

πŸ‡ΊπŸ‡Έ

Winston Salem, North Carolina, United States

Community Research Initiative on AIDS

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Research Services 2000 Inc

πŸ‡ΊπŸ‡Έ

Fort Worth, Texas, United States

Novum Inc

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Arizona Clinical Research Ctr Inc

πŸ‡ΊπŸ‡Έ

Tucson, Arizona, United States

Javier O Morales Ramirez

πŸ‡΅πŸ‡·

San Juan, Puerto Rico

Phoenix Body Positive

πŸ‡ΊπŸ‡Έ

Phoenix, Arizona, United States

Univ Med Ctr / HIV Wellness Ctr

πŸ‡ΊπŸ‡Έ

Las Vegas, Nevada, United States

Univ of Miami School of Medicine

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

Ctr for Quality Care

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

Daniel Seekins

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

Infectious Disease Research Institute

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

Montrose Clinic

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

UT-Health Science Ctr

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

Infectious Diseases

πŸ‡ΊπŸ‡Έ

Indianapolis, Indiana, United States

Kansas City AIDS Research Consortium

πŸ‡ΊπŸ‡Έ

Kansas City, Missouri, United States

Univ of Nebraska Med Ctr / HIV Clinic

πŸ‡ΊπŸ‡Έ

Omaha, Nebraska, United States

Diagnostic Clinic of San Antonio

πŸ‡ΊπŸ‡Έ

San Antonio, Texas, United States

Novum Inc / Pharmaceutical Research Services

πŸ‡ΊπŸ‡Έ

Seattle, Washington, United States

Infectious Diseases Associates

πŸ‡ΊπŸ‡Έ

Milwaukee, Wisconsin, United States

AIDS Healthcare Foundation

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Β© Copyright 2025. All Rights Reserved by MedPath